Christopher Dean

2.0k total citations
78 papers, 1.6k citations indexed

About

Christopher Dean is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Christopher Dean has authored 78 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Radiology, Nuclear Medicine and Imaging, 29 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Christopher Dean's work include Monoclonal and Polyclonal Antibodies Research (44 papers), HER2/EGFR in Cancer Research (20 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Christopher Dean is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (44 papers), HER2/EGFR in Cancer Research (20 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Christopher Dean collaborates with scholars based in United Kingdom, United States and India. Christopher Dean's co-authors include Helmout Modjtahedi, S. A. Eccles, G. Box, Jennifer A. Leeds, Steve Hobbs, Martin Pagé, M. Rufus Crompton, Niall MacDougall, Michael J. Tilby and J Sandle and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Christopher Dean

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Dean United Kingdom 24 688 660 656 285 262 78 1.6k
J.-P. Mach Switzerland 27 867 1.3× 678 1.0× 1.6k 2.5× 481 1.7× 227 0.9× 65 2.4k
William K. Dahlberg United States 18 836 1.2× 369 0.6× 281 0.4× 113 0.4× 206 0.8× 36 1.3k
Ingrid Hofland Netherlands 19 830 1.2× 863 1.3× 249 0.4× 341 1.2× 486 1.9× 36 2.1k
M. V. Pimm United Kingdom 29 769 1.1× 682 1.0× 1.2k 1.8× 659 2.3× 230 0.9× 123 2.3k
Craig D. Peacock United States 22 1.2k 1.8× 1.1k 1.7× 110 0.2× 352 1.2× 299 1.1× 47 2.3k
Magali Schreyer Switzerland 24 747 1.1× 531 0.8× 1.2k 1.8× 702 2.5× 119 0.5× 40 2.0k
Stefan Stangl Germany 25 802 1.2× 243 0.4× 289 0.4× 376 1.3× 145 0.6× 55 1.5k
Hub F. J. Dullens Netherlands 19 326 0.5× 298 0.5× 226 0.3× 437 1.5× 121 0.5× 71 1.1k
Jennifer M. Specht United States 27 685 1.0× 1.1k 1.7× 766 1.2× 469 1.6× 475 1.8× 106 2.4k
Mala Chakraborty United States 21 564 0.8× 2.1k 3.2× 462 0.7× 2.0k 6.8× 499 1.9× 33 3.1k

Countries citing papers authored by Christopher Dean

Since Specialization
Citations

This map shows the geographic impact of Christopher Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Dean more than expected).

Fields of papers citing papers by Christopher Dean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Dean. The network helps show where Christopher Dean may publish in the future.

Co-authorship network of co-authors of Christopher Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Dean. A scholar is included among the top collaborators of Christopher Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Dean. Christopher Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dean, Christopher, et al.. (2025). STAG2 mutations in the normal colon induce upregulation of oncogenic pathways in neighbouring wildtype cells. PLoS ONE. 20(10). pone.0332499.exml–pone.0332499.exml.
2.
Dean, Christopher, et al.. (2016). Assessment of a carbon fibre MRI flatbed insert for radiotherapy treatment planning. British Journal of Radiology. 89(1062). 20160108–20160108. 14 indexed citations
3.
Smith, David W., Christopher Dean, & J. Lilley. (2011). A practical method of identifying data loss in 4DCT. Radiotherapy and Oncology. 102(3). 393–398. 4 indexed citations
4.
Smith, David W., et al.. (2010). Dosimetric characterization of the iBEAM evo carbon fiber couch for radiotherapy. Medical Physics. 37(7Part1). 3595–3606. 28 indexed citations
5.
Sykes, Jonathan, et al.. (2008). Measurement of cone beam CT coincidence with megavoltage isocentre and image sharpness using the QUASAR™ Penta-Guide phantom. Physics in Medicine and Biology. 53(19). 5275–5293. 20 indexed citations
6.
Dean, Christopher. (2003). Preparation and Testing of Monoclonal Antibodies to Recombinant Proteins. Humana Press eBooks. 10. 43–64. 3 indexed citations
7.
Hiles, Ian D., et al.. (1998). Two erbB-4 transcripts are expressed in normal breast and in most breast cancers. Oncogene. 17(7). 919–924. 42 indexed citations
8.
Dean, Christopher, et al.. (1997). Methodology for selection of human antibodies to membrane proteins from a phage-display library. Journal of Immunological Methods. 204(2). 193–203. 18 indexed citations
9.
Modjtahedi, Helmout & Christopher Dean. (1996). Monoclonal Antibodies to the EGF Receptor Act as Betacellulin Antagonists. Biochemical and Biophysical Research Communications. 221(3). 625–630. 10 indexed citations
10.
Kamalati, Tahereh, Helen E. Jolin, Philip J. Mitchell, et al.. (1996). Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor. Journal of Biological Chemistry. 271(48). 30956–30963. 98 indexed citations
11.
Modjtahedi, Helmout, Tamas Hickish, Margery Nicolson, et al.. (1996). Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer. British Journal of Cancer. 73(2). 228–235. 82 indexed citations
12.
Tilby, Michael J., et al.. (1995). A monoclonal antibody that recognizes alkali-stabilized melphalan-DNA adducts and its application in immunofluorescence microscopy. Carcinogenesis. 16(8). 1895–1901. 10 indexed citations
13.
Eccles, Sue, et al.. (1994). Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.. PubMed. 54(19). 5171–7. 56 indexed citations
14.
Dean, Christopher, et al.. (1994). Immunotherapy with antibodies to the EGF receptor. International Journal of Cancer. 57(S8). 103–107. 20 indexed citations
15.
Modjtahedi, Helmout, S. A. Eccles, G. Box, Jennifer Styles, & Christopher Dean. (1993). Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophysics. 22(1-3). 129–146. 17 indexed citations
16.
Tilby, M.J., David R. Newell, Peter J. Selby, C. Viner, & Christopher Dean. (1993). Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy. European Journal of Cancer. 29(5). 681–686. 18 indexed citations
17.
Davidson, Brian R, Helen Young, Wendy A. Waddington, et al.. (1992). Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody. Cancer. 69(3). 620–625. 9 indexed citations
18.
Cordell, J L, John P. Moore, Christopher Dean, et al.. (1991). Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in Vitro. Virology. 185(1). 72–79. 50 indexed citations
19.
20.
Tuzi, Nadia L., et al.. (1988). Production and characterization of monoclonal antibodies to the c-erbB-2 proto-oncogene protein using a synthetic peptide immunogen. Biochemical Society Transactions. 16(5). 675–677. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.-P. Mach Breakdown of academic impact, for papers by William K. Dahlberg Breakdown of academic impact, for papers by Ingrid Hofland Breakdown of academic impact, for papers by M. V. Pimm Breakdown of academic impact, for papers by Craig D. Peacock Breakdown of academic impact, for papers by Magali Schreyer Breakdown of academic impact, for papers by Stefan Stangl Breakdown of academic impact, for papers by Hub F. J. Dullens Breakdown of academic impact, for papers by Jennifer M. Specht Breakdown of academic impact, for papers by Mala Chakraborty
Rankless by CCL
2026